Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Partial Down-titration of Guideline-directed Medical Therapy in Heart Failure in Remission
NCT07513883Phase 4Recruiting
- Sponsor
- Ziekenhuis Oost-Limburg
- Start
- Mar 2026
- Primary completion
- Sep 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol, canrenoic acid in heart failure (HF), sponsored by Ziekenhuis Oost-Limburg. Started Mar 2026; status: recruiting.
02
Drugs
carvedilolcanrenoic acid
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT07513883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07513883.